PCN102 - Cost-Effectiveness Analysis of Bendamustine-Rituximab Treatment Compared with Fludarabine-Rituximab Treatment, in Patients with Indolent Non-Hodgkin’s Lymphoma in Costa Rica
| Autor: | Desanvicente-Celis, Z., Obando, C.A., Chaves, M., Gonzalez, L., Muschett, D. |
|---|---|
| Zdroj: | In Value in Health May 2014 17(3):A85-A85 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect